Foreigners and Institutions Net Buying Push KOSPI Up Over 0.5% in Early Trading

The KOSPI, which showed a slight decline in the early session, is showing an upward trend due to net buying by foreigners and institutions.

At 9:18 a.m. on the 22nd, the KOSPI stood at 2550.53, up 0.5% (12.74 points) from the previous trading day. The KOSPI opened at 2540.03, up 0.09% (2.24 points) from the previous trading day. In the early session, the KOSPI did not show a clear upward trend due to difficulties in the US debt ceiling negotiations. Han Ji-young, a researcher at Kiwoom Securities, said, "The debt ceiling negotiation issue dominates the overall stock market news, which could cause stock price volatility."

However, as foreigners and institutions bought stocks worth 16.4 billion KRW and 16.2 billion KRW respectively, both engaging in net buying, the market appears to be turning upward. At this time, individual investors sold stocks worth 38.8 billion KRW alone.

Looking at the top market capitalization stocks, Samsung Electronics is up 0.44% from the previous trading day at 68,700 KRW. Other stocks showing an upward trend include LG Energy Solution (0.36%), LG Chem (0.29%), Samsung SDI (0.43%), SK Hynix (0.51%), Samsung Biologics (1.03%), and Hyundai Motor (0.49%). NAVER fell 0.92%.

At the same time, the KOSDAQ index stood at 841.44, down 0.03% (0.28 points) from the previous trading day. The KOSDAQ index opened at 840.97, down 0.09% (0.75 points) from the previous trading day, and fell more than 0.4% at one point, but is currently narrowing the decline. Looking at investor trends, individual investors bought stocks worth 57.6 billion KRW alone, while foreigners and institutions sold stocks worth 48.8 billion KRW and 8.2 billion KRW respectively.

Among the top market capitalization stocks, EcoPro BM fell 1.99%, and EcoPro also dropped 3.2%. Others that declined include L&F (-0.84%), HLB (-1.38%), JYP Ent. (-1.9%), Kakao Games (-1.02%), Pearl Abyss (-0.65%), and Osstem Implant (-0.42%). Celltrion Healthcare (2.02%) and Celltrion Pharm (1.75%) showed an upward trend.